galantamine has been researched along with propidium iodide in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrisano, V; Banzi, R; Bartolini, M; Bergamini, C; Bolognesi, ML; Cattaneo, A; Cavalli, A; Fato, R; Hrelia, P; Lenaz, G; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tarozzi, A; Tumiatti, V | 1 |
| Agnusdei, M; Belinskaya, T; Borriello, M; Brindisi, M; Butini, S; Campiani, G; Catalanotti, B; Fattorusso, C; Fiorini, I; Gemma, S; Nacci, V; Novellino, E; Panico, A; Persico, M; Ros, S; Saxena, A | 1 |
| Andrisano, V; Bartolini, M; Bolognesi, ML; Cavalli, A; Mancini, F; Melchiorre, C; Micco, M; Milelli, A; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V | 1 |
| Gu, LQ; Huang, SL; Huang, ZS; Ma, L; Ning, FX; Qiao, W; Tang, H; Wei, YB; Zhang, C | 1 |
| Arnold, N; Brandt, W; Geissler, T; Kehlen, A; Porzel, A; Schlenzig, D; Wessjohann, L | 1 |
| Alvarez-Pérez, M; Chioua, M; Gandía, L; García, AG; González-Lafuente, L; López, MG; Marco-Contelles, J; Ríos, Cde L; Roda, JM; Romero, A; Samadi, A; Soriano, E; Villarroya, M | 1 |
| Beazely, MA; Mohamed, T; Rao, PP; Vasefi, MS; Yeung, JC | 1 |
| Akfur, C; Allgardsson, A; Andersson, CD; Berg, L; Ekström, F; Engdahl, C; Forsgren, N; Linusson, A; Qian, W | 1 |
8 other study(ies) available for galantamine and propidium iodide
| Article | Year |
|---|---|
Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Butyrylcholinesterase; Cell Line; Cholinesterase Inhibitors; Humans; Ligands; Models, Molecular; NAD(P)H Dehydrogenase (Quinone); Oxidative Stress; Polyamines; Protein Binding; Quinones; Reactive Oxygen Species; Structure-Activity Relationship; Substrate Specificity | 2007 |
Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.
Topics: Acetylcholinesterase; Binding Sites; Butyrylcholinesterase; Cholinesterase Inhibitors; Computational Biology; Crystallography, X-Ray; Drug Design; Humans; Models, Molecular; Protein Conformation; Structure-Activity Relationship; Tacrine | 2008 |
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inner spacer.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Cholinesterase Inhibitors; Drug Design; Ligands; Molecular Structure; Polyamines; Stereoisomerism; Structure-Activity Relationship | 2008 |
Synthesis, biological evaluation and molecular modeling of oxoisoaporphine and oxoaporphine derivatives as new dual inhibitors of acetylcholinesterase/butyrylcholinesterase.
Topics: Acetylcholinesterase; Alkaloids; Animals; Aporphines; Butyrylcholinesterase; Computer Simulation; Crystallography, X-Ray; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Models, Chemical; Models, Molecular; Molecular Structure; Reproducibility of Results; Stereoisomerism; Torpedo | 2009 |
Acetylcholinesterase inhibitors from the toadstool Cortinarius infractus.
Topics: Acetylcholinesterase; Agaricales; Animals; Cattle; Cholinesterase Inhibitors; Erythrocytes; Fruiting Bodies, Fungal; Heterocyclic Compounds, 4 or More Rings; Molecular Structure; Stereoisomerism; Structure-Activity Relationship | 2010 |
Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyri
Topics: Acetylcholinesterase; Alzheimer Disease; Aminopyridines; Animals; Butyrylcholinesterase; Cell Line, Tumor; Cholinergic Agents; Cholinesterase Inhibitors; Electrophorus; Horses; Humans; Models, Molecular; Neurons; Neuroprotective Agents; Nitriles; Pyridines; Vascular Diseases | 2010 |
Development and evaluation of multifunctional agents for potential treatment of Alzheimer's disease: application to a pyrimidine-2,4-diamine template.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Cell Survival; Diamines; Humans; Models, Molecular; Molecular Structure; Pyrimidines; Retinoblastoma; Structure-Activity Relationship | 2012 |
Divergent structure-activity relationships of structurally similar acetylcholinesterase inhibitors.
Topics: Acetylcholinesterase; Animals; Benzene Derivatives; Binding Sites; Biphenyl Compounds; Cholinesterase Inhibitors; Crystallography, X-Ray; Enzyme Assays; Enzyme Reactivators; Hydrolysis; Mice; Molecular Structure; Naphthalenes; Protein Binding; Structure-Activity Relationship; Sulfonamides; Thermodynamics | 2013 |